Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia

Abstract Background Intimal hyperplasia caused by vascular injury is an important pathological process of many vascular diseases, especially occlusive vascular disease. In recent years, Nano-drug delivery system has attracted a wide attention as a novel treatment strategy, but there are still some c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Boyan Liu, Wenhua Yan, Li Luo, Shuai Wu, Yi Wang, Yuan Zhong, Dan Tang, Ali Maruf, Meng Yan, Kun Zhang, Xian Qin, Kai Qu, Wei Wu, Guixue Wang
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/de17b6f5adb5453baabb43715c6d3fe3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:de17b6f5adb5453baabb43715c6d3fe3
record_format dspace
spelling oai:doaj.org-article:de17b6f5adb5453baabb43715c6d3fe32021-11-21T12:29:28ZMacrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia10.1186/s12951-021-01119-51477-3155https://doaj.org/article/de17b6f5adb5453baabb43715c6d3fe32021-11-01T00:00:00Zhttps://doi.org/10.1186/s12951-021-01119-5https://doaj.org/toc/1477-3155Abstract Background Intimal hyperplasia caused by vascular injury is an important pathological process of many vascular diseases, especially occlusive vascular disease. In recent years, Nano-drug delivery system has attracted a wide attention as a novel treatment strategy, but there are still some challenges such as high clearance rate and insufficient targeting. Results In this study, we report a biomimetic ROS-responsive MM@PCM/RAP nanoparticle coated with macrophage membrane. The macrophage membrane with the innate “homing” capacity can superiorly regulate the recruitment of MM@PCM/RAP to inflammatory lesion to enhance target efficacy, and can also disguise MM@PCM/RAP nanoparticle as the autologous cell to avoid clearance by the immune system. In addition, MM@PCM/RAP can effectively improve the solubility of rapamycin and respond to the high concentration level of ROS accumulated in pathological lesion for controlling local cargo release, thereby increasing drug availability and reducing toxic side effects. Conclusions Our findings validate that the rational design, biomimetic nanoparticles MM@PCM/RAP, can effectively inhibit the pathological process of intimal injury with excellent biocompatibility. Graphical AbstractBoyan LiuWenhua YanLi LuoShuai WuYi WangYuan ZhongDan TangAli MarufMeng YanKun ZhangXian QinKai QuWei WuGuixue WangBMCarticleIntimal hyperplasiaNanomedicineTargeted deliveryMacrophagesROS-responsiveBiotechnologyTP248.13-248.65Medical technologyR855-855.5ENJournal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-19 (2021)
institution DOAJ
collection DOAJ
language EN
topic Intimal hyperplasia
Nanomedicine
Targeted delivery
Macrophages
ROS-responsive
Biotechnology
TP248.13-248.65
Medical technology
R855-855.5
spellingShingle Intimal hyperplasia
Nanomedicine
Targeted delivery
Macrophages
ROS-responsive
Biotechnology
TP248.13-248.65
Medical technology
R855-855.5
Boyan Liu
Wenhua Yan
Li Luo
Shuai Wu
Yi Wang
Yuan Zhong
Dan Tang
Ali Maruf
Meng Yan
Kun Zhang
Xian Qin
Kai Qu
Wei Wu
Guixue Wang
Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia
description Abstract Background Intimal hyperplasia caused by vascular injury is an important pathological process of many vascular diseases, especially occlusive vascular disease. In recent years, Nano-drug delivery system has attracted a wide attention as a novel treatment strategy, but there are still some challenges such as high clearance rate and insufficient targeting. Results In this study, we report a biomimetic ROS-responsive MM@PCM/RAP nanoparticle coated with macrophage membrane. The macrophage membrane with the innate “homing” capacity can superiorly regulate the recruitment of MM@PCM/RAP to inflammatory lesion to enhance target efficacy, and can also disguise MM@PCM/RAP nanoparticle as the autologous cell to avoid clearance by the immune system. In addition, MM@PCM/RAP can effectively improve the solubility of rapamycin and respond to the high concentration level of ROS accumulated in pathological lesion for controlling local cargo release, thereby increasing drug availability and reducing toxic side effects. Conclusions Our findings validate that the rational design, biomimetic nanoparticles MM@PCM/RAP, can effectively inhibit the pathological process of intimal injury with excellent biocompatibility. Graphical Abstract
format article
author Boyan Liu
Wenhua Yan
Li Luo
Shuai Wu
Yi Wang
Yuan Zhong
Dan Tang
Ali Maruf
Meng Yan
Kun Zhang
Xian Qin
Kai Qu
Wei Wu
Guixue Wang
author_facet Boyan Liu
Wenhua Yan
Li Luo
Shuai Wu
Yi Wang
Yuan Zhong
Dan Tang
Ali Maruf
Meng Yan
Kun Zhang
Xian Qin
Kai Qu
Wei Wu
Guixue Wang
author_sort Boyan Liu
title Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia
title_short Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia
title_full Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia
title_fullStr Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia
title_full_unstemmed Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia
title_sort macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia
publisher BMC
publishDate 2021
url https://doaj.org/article/de17b6f5adb5453baabb43715c6d3fe3
work_keys_str_mv AT boyanliu macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia
AT wenhuayan macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia
AT liluo macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia
AT shuaiwu macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia
AT yiwang macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia
AT yuanzhong macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia
AT dantang macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia
AT alimaruf macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia
AT mengyan macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia
AT kunzhang macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia
AT xianqin macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia
AT kaiqu macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia
AT weiwu macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia
AT guixuewang macrophagemembranecamouflagedreactiveoxygenspeciesresponsivenanomedicineforefficientlyinhibitingthevascularintimalhyperplasia
_version_ 1718418976284868608